We spoke to executives from some of healthcare's most prominent vendors to find out what challenges are on their radar in 2022 and beyond. 

Interview with Dhanunjaya Lakkireddy, MD, executive medical director for the Kansas City Heart Rhythm Institute at HCA Midwest Health, on recent advances in electrophysiology (EP) ablation and mapping systems to improve outcomes in atrial fibrillation therapy.

The recall is due to a malfunction risk that could, if not handled properly, cause the pump to stop working for a long period of time. This could lead to a serious injury or death, according to the recall. 

Each topic features valuable insights and demos – in less than 15 minutes - from leading industry thought leaders on important issues in cardiology.

 

“Our ultimate goal is to prevent strokes," one Mayo Clinic electrophysiologist said. "I believe the current study has brought us one step closer.”

Shockwave announced at TCT 2022 that it hopes to enroll up to 400 patients for a new all-female clinical trial.

Joao Cavalcante, MD, of the Minneapolis Heart Institute, discusses new structural heart interventions to treat tricuspid valve regurgitation.

Check out the latest edition of Movers & Shakers, a roundup of the latest executive movements in the healthcare industry.